Getsy Paulina M, Baby Santhosh M, Gruber Ryan B, Gaston Benjamin, Lewis Tristan H J, Grossfield Alan, Seckler James M, Hsieh Yee-Hsee, Bates James N, Lewis Stephen J
Department of Pediatrics, Case Western Reserve University, Cleveland, OH, United States.
Galleon Pharmaceuticals, Inc., Horsham, PA, United States.
Front Pharmacol. 2022 May 26;13:892307. doi: 10.3389/fphar.2022.892307. eCollection 2022.
Endogenous and exogenously administered S-nitrosothiols modulate the activities of central and peripheral systems that control breathing. We have unpublished data showing that the deleterious effects of morphine on arterial blood-gas chemistry (i.e., pH, pCO, pO, and sO) and Alveolar-arterial gradient (i.e., index of gas exchange) were markedly diminished in anesthetized Sprague Dawley rats that received a continuous intravenous infusion of the endogenous S-nitrosothiol, S-nitroso-L-cysteine. The present study extends these findings by showing that unanesthetized adult male Sprague Dawley rats receiving an intravenous infusion of S-nitroso-L-cysteine (100 or 200 nmol/kg/min) markedly diminished the ability of intravenous injections of the potent synthetic opioid, fentanyl (10, 25, and 50 μg/kg), to depress the frequency of breathing, tidal volume, and minute ventilation. Our study also found that the ability of intravenously injected fentanyl (10, 25, and 50 μg/kg) to disturb eupneic breathing, which was measured as a marked increase of the non-eupneic breathing index, was substantially reduced in unanesthetized rats receiving intravenous infusions of S-nitroso-L-cysteine (100 or 200 nmol/kg/min). In contrast, the deleterious effects of fentanyl (10, 25, and 50 μg/kg) on frequency of breathing, tidal volume, minute ventilation and non-eupneic breathing index were fully expressed in rats receiving continuous infusions (200 nmol/kg/min) of the parent amino acid, L-cysteine, or the D-isomer, namely, S-nitroso-D-cysteine. In addition, the antinociceptive actions of the above doses of fentanyl as monitored by the tail-flick latency assay, were enhanced by S-nitroso-L-cysteine, but not L-cysteine or S-nitroso-D-cysteine. Taken together, these findings add to existing knowledge that S-nitroso-L-cysteine stereoselectively modulates the detrimental effects of opioids on breathing, and opens the door for mechanistic studies designed to establish whether the pharmacological actions of S-nitroso-L-cysteine involve signaling processes that include 1) the activation of plasma membrane ion channels and receptors, 2) selective intracellular entry of S-nitroso-L-cysteine, and/or 3) S-nitrosylation events. Whether alterations in the bioavailability and bioactivity of endogenous S-nitroso-L-cysteine is a key factor in determining the potency/efficacy of fentanyl on breathing is an intriguing question.
内源性和外源性给予的S-亚硝基硫醇可调节控制呼吸的中枢和外周系统的活动。我们有未发表的数据表明,在接受内源性S-亚硝基硫醇S-亚硝基-L-半胱氨酸持续静脉输注的麻醉Sprague Dawley大鼠中,吗啡对动脉血气化学指标(即pH、pCO、pO和sO)以及肺泡-动脉氧分压差(即气体交换指标)的有害影响明显减弱。本研究扩展了这些发现,表明接受静脉输注S-亚硝基-L-半胱氨酸(100或200 nmol/kg/min)的未麻醉成年雄性Sprague Dawley大鼠,显著减弱了静脉注射强效合成阿片类药物芬太尼(10、25和50 μg/kg)对呼吸频率、潮气量和分钟通气量的抑制能力。我们的研究还发现,在接受静脉输注S-亚硝基-L-半胱氨酸(100或200 nmol/kg/min)的未麻醉大鼠中,静脉注射芬太尼(10、25和50 μg/kg)干扰正常呼吸(以非正常呼吸指数显著增加来衡量)的能力大幅降低。相比之下,在接受母体氨基酸L-半胱氨酸或D-异构体即S-亚硝基-D-半胱氨酸持续输注(200 nmol/kg/min)的大鼠中,芬太尼(10、25和50 μg/kg)对呼吸频率、潮气量、分钟通气量和非正常呼吸指数的有害影响充分显现。此外,通过甩尾潜伏期试验监测,上述剂量的芬太尼的镇痛作用被S-亚硝基-L-半胱氨酸增强,但未被L-半胱氨酸或S-亚硝基-D-半胱氨酸增强。综上所述,这些发现进一步证明了S-亚硝基-L-半胱氨酸对阿片类药物呼吸抑制有害作用的立体选择性调节,为旨在确定S-亚硝基-L-半胱氨酸的药理作用是否涉及包括1)质膜离子通道和受体的激活、2)S-亚硝基-L-半胱氨酸的选择性细胞内进入和/或3)S-亚硝基化事件的信号转导过程的机制研究打开了大门。内源性S-亚硝基-L-半胱氨酸的生物利用度和生物活性的改变是否是决定芬太尼呼吸作用效力/效果的关键因素,这是一个有趣的问题。